|本期目录/Table of Contents|

[1]王艳玲,刘光万△,吴丽娟,等.新型淀粉基止血材料的制备及生物相容性研究[J].生物医学工程研究,2015,02:102-105.
　WANG Yanling,LIU Guangwan,WU LijuanQU Hongyuan,et al.Fabrication and Biocompatibility Investigation of a Novel Hemostatic Material[J].Journal of Biomedical Engineering Research,2015,02:102-105.
点击复制

新型淀粉基止血材料的制备及生物相容性研究(PDF)

《生物医学工程研究》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年02期
页码:
102-105
栏目:
出版日期:
2015-06-25

文章信息/Info

Title:
Fabrication and Biocompatibility Investigation of a Novel Hemostatic Material
文章编号:
1672-6278 （2015）02-0102-04
作者:
王艳玲1; 2; 刘光万2△; 吴丽娟1; 2; 曲洪媛2; 赵芳2; 杨光1△; 吴昌琳1; 2△
1.华东师范大学物理系，上海磁共振重点实验室，上海 200062；2.苏州博创同康生物工程有限公司，苏州 215347
Author(s):
WANG Yanling1; 2;  LIU Guangwan2;  WU Lijuan1; 2QU Hongyuan2;  ZHAO Fang2;  YANG Guang1;  WU Changlin1; 2
1.Shanghai Key Laboratory of Magnetic Resonance, Physics Department, East China Normal University, Shanghai 200062, China；2.Suzhou Novovita Bio-products Co.Ltd., Suzhou 215347, China
关键词:
淀粉-透明质酸; 冷冻干燥; 交联; 止血; 生物相容性
Keywords:
Starch-hyaluronic acid;  Freeze-drying;  Cross-linking;  Hemostatic;  Biocompatibility
分类号:
R318
DOI:
-
文献标识码:
A
摘要:
以马铃薯淀粉为主要原料，同时添加少量透明质酸和三偏磷酸钠并通过冷冻干燥技术制备一种新型淀粉基止血材料。利用电子显微镜观察其微观结构，用XRD测定其晶体结构，用DSC测定其热稳定性，同时还根据国家标准GB/T16886医疗器械生物学评价标准对其进行生物相容性研究。研究结果表明，此新型淀粉基止血材料呈现三维网络状结构，交联反应发生在非晶区且具有良好的热稳定性。动物实验表明该材料无皮内刺激反应、无致敏、无全身急性毒性及细胞毒性，具有良好的生物相容性。结果表明：该新型淀粉基止血材料在临床应用上具有广阔的前景。
Abstract:
The novel hemostatic material was fabricated from starch, hyaluronic acid and STMP with freeze-drying technique. The microstructure, crystalline structure and thermal stability of the material were studied by SEM, XRD and DSC respectively. And the biocompatibility of this material was investigated by subcutaneous reactivity, sensitization, acute systemic toxicity and cytotoxicity tests described in GB/T16886. The results showed that the crosslinking reaction occurred in amorphous area and this novel hemostatic material presented three-dimensional network structure which was of favourable thermal stability. Animal experiments indicated that the material had no subcutaneous reactivity, no sensitization, no acute systemic reaction and no cytotoxicity. It is concluded that this novel hemostatic material shows promise for clinical applications.

参考文献/References

备注/Memo

备注/Memo:
(收稿日期：2015-02-11)通信作者Email:liuguangw66@163.com；Gyang@phy.ecnu.edu.cn；clwu@phy.ecnu.edu.cn
更新日期/Last Update: 2016-08-09